Detalles de la búsqueda
1.
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
AIDS Patient Care STDS
; 21(8): 533-43, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17711378
2.
Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen only 1 and 2 clinical trials.
J Acquir Immune Defic Syndr
; 40(4): 404-12, 2005 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16280694
Resultados
1 -
2
de 2
1
Próxima >
>>